← All trials
NCT05657652
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2022
- Primary completion
- Oct 31, 2024
- Completion date
- Oct 31, 2024
- First posted
- Dec 20, 2022
- Last posted
- Dec 26, 2022
- Enrollment
- 36
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Soochow UniversityLead sponsor
- Nanjing Medical UniversityCollaborator
- Nanjing Medical UniversityCollaborator
- Soochow UniversityReponsible party - principal investigator
- Nantong UniversityCollaborator
- Bengbu Medical CollegeCollaborator
- Suzhou Hospital of Traditional Chinese MedicineCollaborator
- The Second People's Hospital of Huai'anCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.